Santech Holdings Ltd

Santech Holdings Ltd (STEC) Stock Analysis

$1.530

+0.909 (+59.38%)At close

Loading chart…
High
1.820
Open
1.070
VWAP
1.45
Vol
21.12M
Mkt Cap
—
Low
1.000
Amount
30.62M
EV/EBITDA, TTM
0.00

BitVentures Ltd, formerly known as Santech Holdings Ltd, is a consumer-focused technology company principally engaged in health management service business. The health management services mainly include providing medical examination, chronic disease management, immune system enhancement, and anti-aging solutions. The Company is also exploring new opportunities in technology, including but not limited to new retail, social e-commerce and metaverse. The Company mainly conducts its business within domestic market.

Valuation Metrics

The current forward P/E ratio for Santech Holdings Ltd (STEC) is 0.00, compared to its 5-year average forward P/E of 3.72.

Forward P/E

Undervalued
5Y Average P/E
3.72
Current P/E
0.00
Overvalued
6.72
Undervalued
0.72

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
0.47
Current EV/EBITDA
0.00
Overvalued
1.37
Undervalued
-0.42

Forward P/S

Undervalued
5Y Average P/S
0.37
Current P/S
0.00
Overvalued
0.62
Undervalued
0.12

Alphio AI Price Scenarios for STEC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%STEC

$0.87

Scenario price

B

Base

Base · 50%STEC

$0.75

Scenario price

B

Bear

Bear · 25%STEC

$0.69

Scenario price

Events Timeline

2025-03-12 (ET)

07:10:38

Santech regains compliance with NASDSAQ min bid price requirement

2025-01-22 (ET)

04:06:43

Santech announces change of auditor, files compliance plan with Nasdaq

2024-09-17 (ET)

07:51:11

Santech reports chairman Han Hongwei, CEO Wang Dian have been detained

Show More Events

News

Show More News

STEC FAQ — answered by Alphio AI

BitVentures Ltd, formerly known as Santech Holdings Ltd, is a consumer-focused technology company principally engaged in health management service business. The health management services mainly include providing medical examination, chronic disease management, immune system enhancement, and anti-aging solutions. The Company is also exploring new opportunities in technology, including but not limited to new retail, social e-commerce and metaverse. The Company mainly conducts its business within domestic market. It operates in the Financials sector.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started